Suspected Cancer: recognition and referral (update)Status:In development | In consultationProgramme:NICE guidelineConsultation end date: 2 February 2026Expected publication date: 25 March 2026
Toripalimab with chemotherapy for untreated recurrent or metastatic nasopharyngeal cancer ID6406Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Pembrolizumab before surgery (neoadjuvant) then with radiotherapy after surgery (adjuvant) for newly diagnosed, resectable, locally advanced, squamous cell head and neck cancer [ID6477]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Sentinel Node Biopsy approved for pathological staging of clinically T1-T2 N0 oral cancerStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC